P2Y2 receptor binds ATP and UTP

Stable Identifier
R-HSA-417927
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The P2Y2 receptor (Parr CE et al, 1994) is responsive to both adenosine and uridine nucleotides. It may participate in control of the cell cycle of endometrial carcinoma cells. Three transcript variants encoding the same protein have been identified for this gene. The effects of P2Y2 are mediated by coupling with the G protein alpha Gq/11 subunits (Schachter JB et al, 1997). P2Y2 is a potential drug target for treating cystic fibrosis (Kellerman D et al, 2002).

Literature References
PubMed ID Title Journal Year
12458155 Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease

Kellerman, D, Evans, R, Mathews, D, Shaffer, C

Adv Drug Deliv Rev 2002
9364473 HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors

Schachter, JB, Sromek, SM, Nicholas, RA, Harden, TK

Neuropharmacology 1997
8159738 Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy

Parr, CE, Sullivan, DM, Paradiso, AM, Lazarowski, ER, Burch, LH, Olsen, JC, Erb, L, Weisman, GA, Boucher, RC, Turner, JT

Proc Natl Acad Sci U S A 1994
Participants
Participant Of
hasEvent
Orthologous Events
Authored
Reviewed
Created